Trial no.:
|
PACTR201308000588258 |
Date of Approval:
|
11/07/2013 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effect of aerobic exercise programme on cardiovascular parameters and CD4 count of subjects living with HIV/AIDS: A randomized controlled trial |
Official scientific title |
Exercise and CD4 count in HIV/AIDS |
Brief summary describing the background
and objectives of the trial
|
The primary objective of this study was to investigate the effect of 8 weeks aerobic exercise training on CD4 count of subjects living with HIV/AIDS
Methods: Age matched randomized controlled trial design was used; subjects living with HIV/AIDS receiving treatment in President¿s Emergency Plan For AIDS Relief (PEPFAR) at the HIV clinic of the University of Nigeria Teaching Hospital, Ituku Ozalla. Enugu. Thirty subjects (N=30) with HIV/AIDS (mean CD4 count range of 504.13±231.61 cells/mm3) were age matched and randomized to two groups: exercise (n= 15) and control (n=15) groups. The exercise group involved in an 8 weeks moderate intensity continuous exercise training (60%--79% HR max) of between 45 and 60 min, 3 times per week, while the controls group remain sedentary. SBP, DBP, VO2 max and CD4 count were assessed. Analysis of co-variance and Pearson correlation tests were used in data analysis
Results: Findings of the study revealed significant effect of moderate intensity continuous exercise training program on, SBP, DBP, VO2max and CD4 count at p< 0.05. Changes in VO2 max significantly correlated with changes in CD4 count (r= .528) at p< 0.05.
Conclusion: It was concluded that moderate intensity aerobic exercise programme is effective adjunct therapy and in boosting the CD4 count in subjects living with HIV/AIDS.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Infections and Infestations,Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
HIV/AIDS |
Purpose of the trial |
Supportive care |
Anticipated trial start date |
07/08/2012 |
Actual trial start date |
07/08/2012 |
Anticipated date of last follow up |
24/10/2012 |
Actual Last follow-up date |
24/10/2012 |
Anticipated target sample size (number of participants) |
33 |
Actual target sample size (number of participants) |
30 |
Recruitment status |
Completed |
Publication URL |
|
|